1.01BMarket Cap-1.87P/E (TTM)
7.520High7.260Low771.11KVolume7.390Open7.340Pre Close5.68MTurnover0.83%Turnover RatioLossP/E (Static)137.72MShares13.09052wk High0.81P/B679.07MFloat Cap6.56052wk Low--Dividend TTM92.52MShs Float141.010Historical High--Div YieldTTM3.54%Amplitude6.560Historical Low7.366Avg Price1Lot Size
Vir Biotechnology Stock Forum
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
*************************************
REVERSE...
Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA Prime Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta
📊⚡️📊
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
📊⚡️📊
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Phase 3 Eclipse Program to Evaluate Tobevibart and Elebsiran
No comment yet